Menu

GRenSSAP
Grup de recerca en Investigació en Serveis

Group leader
Anna_Berenguera 400
Anna Berenguera Ossó
aberenguera@idiapjgol.org
avatar_grups_recerca.png

Projects

Group projects

European non-interventional post-authorization safety study to evaluate cardiovascular events in patients newly exposed to abaloparatide or teriparatide

  • Principal investigators: Talita Duarte Salles
  • Code: 4RNC-0-00322-25
  • Start year: 2026
  • Funders: University of Oxford

TARGET EU – Comparative effectiveness and safety studies using the target trial emulation and estimand frameworks: Rivaroxaban and risk of major gastrointestinal bleeding in elderly patients with non-valvular atrial fibrillation (version 0.3, 10 November 2025)

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00338-25
  • Start year: 2025

A Non-Interventional Multi-Country Post-Authorisation Safety Study (PASS) to Assess the Incidence of Serious Infections & Malignancies in Systemic Lupus Erythematosus (SLE) Patients Exposed to Anifrolumab

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4RNC-0-00379-25
  • Start year: 2026
  • Funders: AstraZeneca Farmacéutica Spain, S.A.

A Randomized, Double-Blind, Controlled Trial to Evaluate the Efficacy and Safety of a Combination of Xyloglucan and Gelose in the treatment of acute diarrhea in adults

  • Principal investigators: Carlen Reyes Reyes
  • Code: 5-0-00007-25
  • Start year: 2025

Sol·licitud premi trajectòria AP ICS 2025 PT

  • Principal investigators: Pere Torán Monserrat
  • Code: 9F-0-00031-25
  • Start year: 2025
  • Funders: ICS - Institut Català de la Salut

Board of Trustees

Collaborators

Accreditations